Back
Monopar Therapeutics Stock Price Chart
Pulling an Uber in the $500 Billion Smartphone Industry
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
77
MNPR
Monopar Therapeutics
Last Price:
$39.20
Seasonality Move:
-13.19%
7 Day Trial
ALL ACCESS PASS
$
7
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.16 | Buy |
| 20-day SMA: | 26.34 | Buy |
| 50-day SMA: | 23.59 | Buy |
| 200-day SMA: | 9.39 | Buy |
| 8-day EMA: | 31.45 | Buy |
| 20-day EMA: | 27.86 | Buy |
| 50-day EMA: | 23.35 | Buy |
| 200-day EMA: | 12.66 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.95 | Buy |
| Relative Strength Index (14 RSI): | 75.21 | Buy |
| Chaikin Money Flow: | 81027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.5 - 30.58) | Buy |
| Bollinger Bands (100): | (5.71 - 25.15) | Buy |
Monopar Therapeutics Technical Analysis
| Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 39.32 while MNPR 8-day simple moving average is 30.16, which is a Buy signal.
-
The stock price of MNPR is 39.32 while Monopar Therapeutics 20-day SMA is 26.34, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 23.59 while MNPR share price is 39.32, making it a Buy technically.
-
MNPR stock price is 39.32 and Monopar Therapeutics 200-day simple moving average is 9.39, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
77
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $39.32. The Score for MNPR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
207.5M
Price in USD:
39.32
Share Volume:
102.1K
Monopar Therapeutics 52-Week Range
52-Week High:
39.99
52-Week Low:
1.55
Buy
77
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 39.32 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 39.32 while MNPR 8-day exponential moving average is 31.45, which is a Buy signal.
-
The stock price of MNPR is 39.32 while Monopar Therapeutics 20-day EMA is 27.86, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 23.35 while MNPR share price is 39.32, making it a Buy technically.
-
MNPR stock price is 39.32 and Monopar Therapeutics 200-day simple moving average is 12.66, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.41 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 2.95, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 75.21, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (22.5 - 30.58), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (5.71 - 25.15), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.